CCM
PODD icon

Chimera Capital Management’s Insulet PODD Stock Holding History

Chimera Capital Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,737
Closed -$857K – 247
2022
Q3 		$857K Buy
+3,737
New +$936K 0.24% 97

Other funds holding PODD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chimera Capital Management's PODD Position: Q4 2022 in Review

Chimera Capital Management sold out of Insulet (PODD) in Q4 2022, closing a stake of 3,737 shares — an estimated $857K sold.

Chimera Capital Management first reported a position in PODD in Q3 2022 and held it in 1 quarter. The position peaked at $857K in Q3 2022. 525 funds tracked by Wall St. Rank hold PODD as of Q4 2022.

  • Chimera Capital Management reported no remaining Insulet position as of Q4 2022 after selling out during the quarter.
  • Chimera Capital Management sold 3,737 Insulet shares in Q4 2022, an estimated $857K.
  • Chimera Capital Management first reported a position in Insulet in Q3 2022 and held it in 1 quarter.
  • Chimera Capital Management's Insulet position peaked at $857K in Q3 2022.
  • 525 funds tracked by Wall St. Rank held Insulet as of Q4 2022.

Based on Chimera Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.